Vascular Closure Devices vs

Slides:



Advertisements
Similar presentations
Peripheral vessel: mechanical or chemical closure
Advertisements

Developing a Research Idea Madeline Gervase RN,MSN,CCRN,FNP Advanced Practice Nurse.
CARE OF THE CARDIAC CATH PATIENT Meg Morris, RN, CCRN, Nurse Clinician II Zir Cardiac Cath Lab January 20, 2011.
RadiStop™ Compression Assist Device
TCCC Guidelines: Tourniquets & Hemostatic Agents (Paraphrased)
ECLIPSE Trial: Ensure’s Vascular Closure Device Speeds Hemostasis S. Chiu Wong MD Director, Cardiac Catheterization Laboratories New York Presbyterian.
For Urgent and Unexpected Cases
Vascular Closure Devices. What is a Closure Device Vascular closure devices seal the puncture site in an artery (the arteriotomy) through mechanical means.
IRTB - Arterial Access and Angioplasty Dr Hilary White Nottingham.
Access Site Complications Nick Cheshire MD FRCS, Professor of Vascular Surgery Imperial College Healthcare St Mary’s Hospital Campus.
Percutaneous Insertion Use and Contraindications.
The Radial Approach to Percutaneous Coronary Intervention Is Associated With a Lower Risk for Complications Regardless of Radial Procedure Volume: A Report.
Central Line Removal Competency Assessment for Registered Professional Nurses in the Critical Care Areas References: AACN Procedure Manual for Critical.
Access Site Infections s/p Cardiac Catheterization Procedure Team Members: Michael Jarotkiewicz Eric Grassman, M.D. Fred Leya, M.D. George Simon Jackie.
1 TLB PowerPoint presented By Takaya L. Brown, BSN, BSN, CMSRN.
Coronary Artery Disease: Diagnosis and Treatment
Molina Allen This presentation was prepared for COHP 450, Section VL1, taught by Dr. Njoku.
Conservative Sharp Debridement Nursing Care Responsibilities (Physical Therapy Too) Patricia Gill, MSN, RN, CWON, CHRN.
Wound debridement Available methods for debridement Surgical Sharp Larval Enzymatic Autolytic Mechanical Chemical.
Angie O’Plasty Casey Jernigan Caroline Stovall Amanda Pitts.
“Access Anxiety” John F Eidt MD Ahsan Ali MD Mohammed Moursi MD University of Arkansas for Medical Sciences.
Use of Arteriotomy Closure Devices and the Risk of Vascular Complications: An Analysis of 227,879 Patients in the NCDR Sameer K. Mehta MD, Andrew D. Frutkin.
PCI What You Need to Know!. What and Where Radial- advantages  Immediate ambulation  Easily compressible vessel  Less risk of nerve injury  Dual blood.
Arterial access פרופ ' אריאל רוגין מנהל היחידה לקרדיולוגיה פולשנית מרכז רפואי רמב " ם, חיפה.
Cardiac Cath and Angiocardiography Adult II FINAL 2/2015.
Results 10/10 nurses surveyed stated that bed rest times are determined by the patient’s provider, which is based off of provider preference because there.
Hemostasis after Trans Radial Intervention Division of Cardiology, Department of Internal Medicine Dongguk University Gyeongju Hospital Deuk-Young Nah,
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Trends in Vascular Complications After Diagnostic.
Zoltan G. Turi, M.D. Cooper University Hospital Cooper Medical School of Rowan University Camden, NJ Vascular Access and Closure.
Clinical Implications of D-Stat ® Dry in the Trauma Setting Gundu H. R. Rao*, Debra Cocking Johnson*, Steve Penegor**, Daniella Jentzsch** *Blood Biocompatibility.
Impact of Anticoagulation Regimens on Sheath Management and Bleeding in Patients Undergoing Elective Percutaneous Coronary Intervention in the STEEPLE.
KOVAI MEDICAL CENTER AND HOSPITAL, COIMBATORE, INDIA
Zoltan G. Turi, M.D. Professor of Medicine University of Medicine and Dentistry of New Jersey A Bad Vascular Access and Closure Outcome.
Antegrade Femoral Artery Access
Nelson Lim Bernardo, MD Washington Hospital Center
Radial Access: Lots of Publicity, But What is the Reality?
Randomized vs. Observational Studies: Strengths and Weaknesses
Access Closure Devices: A Changing Paradigm
Clinical Trial Design for Second Generation TAVI - Academic View
How To Minimize Bleeding In The Cath Lab
Transfemoral Access Devices & Tips for Closure Devices
Management of Patients on Chronic Oral Anticoagulant Therapy
Vascular Closure Techniques
The CLOSER Trial: A Multicenter Study on the Clinical Safety and Effectiveness of Closer™ VSS, a Novel Resorbable Transfemoral Vascular Access Sealing.
Manual Compression: “Still the Gold Standard”
Transfemoral Access Devices & Tips for Closures Devices
University Emergency Hospital «Pirogov» Sofia
PCI related in-hospital mortality based on race and gender in the USA
Bhalaghuru Chokkalingam Mani MD
Clinical Trials Medical Interventions
Paravalvular Leak Closure Case Presentation
For the CLOSE-UP study group
“Pre-Close” Technique: A Step-by-Step Description
How to Minimize Bleeding in STEMI Patients Outline: -Know about bleeding -Think about consequences of bleeding -Identify bleeding risk factors -Maximize.
Groin Complication from Access Closure Failures
Use of NOACs is contraindicated for AF patients with mechanical prosthetic valves or moderate- severe mitral stenosis (usually of rheumatic origin). Although.
Vascular Access and Vascular Closure Devices
Clinical Trials.
Patented Technology to Seal Arterial Access Sites
Carlos F. Bechara, MD, Suman Annambhotla, MD, Peter H. Lin, MD 
How and why this study may change my practice ?
RESTRAINT & SECLUSION(R/S) for NON-NURSING
Redmond Fire & Rescue Community Paramedicine
Transradial access compared with femoral puncture closure devices in percutaneous coronary procedures  Alessandro Sciahbasi, Dionigi Fischetti, Amedeo.
Vision of relevant technologic progress for the next two decades
Complication rates following 4-Fr versus 6-Fr transfemoral vascular access – prospective audit at a single centre Chung R1, Weller A1, Bowles C1, Sedgwick.
Increase interdisciplinary communication
Before You Start: Evaluation of the Patient and the Procedure
Larger Sheath Size for Infrainguinal Endovascular Intervention is Associated with Minor but Not Major Morbidity or Mortality Scott R. Levin MD, Alik.
Presentation transcript:

Vascular Closure Devices vs Vascular Closure Devices vs. Manual Compression Vascular Closure Devices: The New Gold Standard KENNETH A. GORSKI, RN, RCIS, RCSA, FSICP Cleveland Clinic Heart and Vascular Intstitute Cleveland, Ohio

Kenneth A. Gorski, RN, RCIS, RCSA, FSICP I disclose the following: Regina Deible CONNED me into this. I believe there are appropriate applications for both Manual Compression and Vascular Closure Devices. Square pegs will not fit into round holes without the aid of a hammer. Now, I have Seven Minutes to convince you otherwise. On top of that, nobody told me upfront I would be debating my friend Michael Guiry. “Oh, by the way . . . “ Over the years, I have done lectures and consulting for the Medicines Company, St. Jude, HemCon, Volcano, and a number of other companies willing to buy me a Starbucks coffee, dinner, or pay me a paltry fee compared to what they will pay physicans. So, I have no real or apparent conflicts of interest to report r/t this lecture None of this reported above will impact my ability to present an unbiased presentation

Manual Compression Is it really “The Gold Standard” in Sheath Removal? MC has a 60 year track record Very little published information on proper technique Technique varies from institution to institution, even person to person

Hematoma Post Manual Compression http://www.cardivamedical.com picture gallery accessed 2/8/2010

Compression Vascular Closure Devices Compression Devices “C-Clamps” and “Manual Assists” CompressAR – Advanced Vascular Dynamics QuicKlamp – TZ Medical EZ-Hold (TZ Medical) Compass (Advanced Vascular Dynamics) FemoStop (St. Jude) SafeGuard (Datascope/Maquet) Topical Hemostasis Accelerators Syvek – Marine Polymers ChitoSeal – Abbott Vascular Clo-Sur P.A.D. – Scion CV/Medtronic V+Pad – Angiotech HemCon – HemCon/Cardinal Health Many, many more

Pseudo-Mechanical Vascular Closure Device Cardiva Boomerang/Catalyst products are designed to allow smooth muscle recoil around the puncture, “shrinking” the arteriotomy and reducing manual hold time (Catalyst III coated with Protamine to accelerate tract clotting)

Mechanical Vascular Closure Devices Collagen / Gelfoam Plugs AngioSeal (St. Jude Medical) VasoSeal (St. Jude – Limited availability) QuickSeal (SubQ; no longer available) Tissue Tract “Sealers” Duett (Vascular Solutions – viscous thrombin/collagen procoagulant) Mynx (Access Closure)

Mechanical Vascular Closure Devices Percutaneous Suture Devices Perclose Products (Abbott Vascular) Percutaneous Vascular Staples StarClose (Abbott Vascular)

Why Vascular Closure???

Hemostasis Success Rates Manual Compression 100% Successful - All bleeding stops Eventually Vascular Closure Devices High Success Rates for both Diagnostic and PCI * Success difficult to assess d/t No Standardized Definition for Hemostasis in VCD Trials and Registries

Time to Hemostasis Manual Compression Vascular Closure Devices 10-15 minutes dependant on sheath size 15+ minutes larger sheaths, obese patients, chronic renal insufficiency, and other associated risk factors Interventional patient require 2 or more hours for anticoagulation to wear off prior to sheath removal Vascular Closure Devices Immediate Gratification Hemostasis within a couple minutes of the end of the procedure

Bedrest and Time to Ambulation Manual Compression Bedrest dependent on sheath size and age of physician (some physicians still practice 1 hour bedrest per French size) Interventional patient supine or head of bed < 30O for 2 or more hours until anticoagulation wears off for sheath removal Post sheath removal additional bedrest, many cases overnight Vascular Closure Devices Bedrest 1-2 hours for diagnostic; some cases immediate ambulation after sedation worn off Interventional patients supine or head of bed < 45O for 2-4 hours Dependent on physician, may sit up on side of bed or ambulate after 4 hours (many will not allow to ambulate until next morning)

Patient Comfort Manual Compression Longer bedrest Back pain in many patients Improper/Poor technique – Fisting / “Gorilla Groin” Obesity High Sticks Renal dysfunction Large sheaths All lead to prolonged manual compression and extreme patient discomfort

Gorilla Groin!

Patient Comfort Vascular Closure Devices “Frequent Flyers” most often prefer VCD over Manual Compression Some patients report tugging, pressure associated with device deployment as most painful part of procedure Primary effect of conscious sedation generally worn off when device deployed

Very Operator Dependent Manual Compression Very Operator Dependent Poor Technique = Poor Hemostasis = Poor Outcome

Mechanical Closure Devices Also Operator Dependent, however Newer generation devices are easier to use, eliminated excess steps, and have less operator variability

Poor Technique = Poor Hemostasis NO MATTER WHAT METHOD IS USED Poor Technique = Poor Hemostasis = Poor Outcome

#1 Risk Factor for Femoral Access Site Complications OBESITY Do you want to hold THAT groin?

Bring in this guy for that hold . . .

Just say NO! GO RADIAL!

Please Support the Gorski Boy’s College Fund Jonathan Gorski - High School Freshman Eats non-stop Kenny Gorski – High School Senior Class of 2010 David Gorski – Malone University Triple Major Music Ed/Gen Ed/ Poli Sci

THE END !